Walker on Progress

A new HHS agenda reopens the door for controversial peptides, just as a wave of next-gen obesity drugs threatens to upend the entire market.

The music legend invests in a fast-growing wellness beverage, signaling a major shift in the multi-billion dollar industry toward healthier alternatives.

Florida's only GitHub Copilot Dev Days, sponsored by NLP Logix, brings industry giants to Jacksonville to explore the future of AI-assisted development.

The Chinese AI credit platform's latest ESG report signals a growing focus on sustainability and social impact amid tightening market and regulatory pressures.

A prestigious World Travel Awards nomination for Privé Jets highlights a booming private jet sector in South America, driven by economic and logistical needs.

Chicago's iconic vertical mall unveils a massive redevelopment, shrinking retail and adding offices to spark a new era for the Magnificent Mile.

One of the nation's largest dental groups just erased over a billion in debt. This move reveals the high-stakes finance behind your dentist's office.

The addition of a new physician in St. Petersburg highlights the statewide boom in personalized medicine and a growing focus on specialized women's healthcare.

With nearly 50,000 passengers expected, Montreal's 2026 cruise season focuses on high-end ships, extended stays, and sustainable growth.

As temperatures rise, many HVAC companies see revenues soar but profits plummet. A new report reveals the hidden financial traps draining busy businesses.

Riding a wave of record profits and a soaring stock price, TTM Technologies prepares to outline its future growth strategy at its 2026 Investor Day.

With revenue declining and subscribers dropping, Peloton's May 7th earnings report is a critical test of its new strategies and path to profitability.

New research reveals a major shift: cold wallet users are active traders, not passive hoarders. But a huge perception gap is slowing mass adoption.

A breakthrough review validates harnessing neutrophils, the immune system's foot soldiers, for cancer, with a new therapy now heading to human trials.

An award-winning James Hardie partner expands to Wisconsin, promising to raise the standard for home exteriors with climate-tested, design-forward solutions.

A novel drug derived from ibogaine, DMX-1001 aims to repair brain circuits damaged by alcohol. The FDA has now cleared it for Phase 2 human trials.

Hundreds of lupus advocates descended on Washington, demanding policy reform and research funding, and their persistent efforts are already yielding major results.

A landmark acquisition creates Canada's largest employee ownership advisor just as a critical tax incentive for business transitions faces a looming deadline.

A new report reveals cybercriminals are bypassing firewalls by exploiting human behavior, with vendor email scams and social engineering on the rise.

A record-breaking medical conference reveals a major shift in medicine, as practitioners move from simply managing aging to pursuing biological age reversal.